Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP314061.RA4_QiGHg3_rCak5QxCWprn-VtPoMD1_tmb-3AKxHqrng130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP314061.RA4_QiGHg3_rCak5QxCWprn-VtPoMD1_tmb-3AKxHqrng130_assertion type Assertion NP314061.RA4_QiGHg3_rCak5QxCWprn-VtPoMD1_tmb-3AKxHqrng130_head.
- NP314061.RA4_QiGHg3_rCak5QxCWprn-VtPoMD1_tmb-3AKxHqrng130_assertion description "[Of the ten haemoglobinopathies, in four (the Hb San Diego, the Hb Johnstown, the Hb Malm� and the Hb Columbia-Missouri), the change of amino acid affects zones of the contact alpha(1)beta(2); in two variants (the Hb Strasbourg and the Hb Syracuse), it affects the unions with 2,3-DPG in the central cavity; in the other two (the Hb Badalona and the Hb La Coru�a), the cavity of contact with the group haem is affected; in one (Hb Bethesda), it affects the zone of contact alpha(1)beta(1;) and in one (Hb Olympia), the position 20 of the chain in the helix B in the surface of the protein is affected.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP314061.RA4_QiGHg3_rCak5QxCWprn-VtPoMD1_tmb-3AKxHqrng130_provenance.
- NP314061.RA4_QiGHg3_rCak5QxCWprn-VtPoMD1_tmb-3AKxHqrng130_assertion evidence source_evidence_literature NP314061.RA4_QiGHg3_rCak5QxCWprn-VtPoMD1_tmb-3AKxHqrng130_provenance.
- NP314061.RA4_QiGHg3_rCak5QxCWprn-VtPoMD1_tmb-3AKxHqrng130_assertion SIO_000772 18818920 NP314061.RA4_QiGHg3_rCak5QxCWprn-VtPoMD1_tmb-3AKxHqrng130_provenance.
- NP314061.RA4_QiGHg3_rCak5QxCWprn-VtPoMD1_tmb-3AKxHqrng130_assertion wasDerivedFrom befree-20140225 NP314061.RA4_QiGHg3_rCak5QxCWprn-VtPoMD1_tmb-3AKxHqrng130_provenance.
- NP314061.RA4_QiGHg3_rCak5QxCWprn-VtPoMD1_tmb-3AKxHqrng130_assertion wasGeneratedBy ECO_0000203 NP314061.RA4_QiGHg3_rCak5QxCWprn-VtPoMD1_tmb-3AKxHqrng130_provenance.